Modelling how point-of-care tests can enable personalised treatment for resistant gonorrhoea infections
Point-of-care tests for infectious diseases: Barriers to implementation across three London teaching hospitals
Benefits of a point of care test for sexual health testing
Managing Mycoplasma genitalium as an STI
The financial and service implications of splitting fixed-dose antiretroviral drugs – a case study
Mapping patient pathways and cost of point of care versus standard testing and treatment for chlamydia and gonorrhoea in sexual health clinics
The cost of managing haematology patients with invasive fungal disease
Treatment for stable HIV patients in England: can we save costs and improve patient care?
The cost-effectiveness of point of care tests for chlamydia and gonorrhoeae in sexual health clinics
Cost effectiveness of screening for Chlamydia trachomatis in Ireland
